ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...
Organ-specific immune-related adverse events and survival in patients with cancer with immune checkpoint inhibitors. Acupuncture as a modality of treatment for chemotherapy-induced peripheral ...
ORLANDO, Fla.--(BUSINESS WIRE)--Hesperos, a leader in recreating human biology with its’ Human-on-a-Chip ® platform, has announced a breakthrough development of a human induced pluripotent stem cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results